Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis

Published:2017-06-06 Issue:1 Volume:28 Page:66-75
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Kanbori Masayoshi¹,Suzuka Hiroshi²,Yajima Tsutomu³,Kishino Emika¹,Morishige Ryuji⁴,Momohara Shigeki⁵,Kawakami Atsushi⁶,Ota Miyo⁴

Affiliation:

1. Japan Safety and Surveillance Division, Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan;

2. Data Management Department, Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan;

3. Biostatistics Department, Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan;

4. Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, Japan;

5. Hakkeikai Incorporated Medical Institution/Department of Orthopaedic Surgery, Keio University, Shizuoka, Japan;

6. Department of Immunology and Rheumatology, Unit of Advanced Preventive Medical Sciences, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1325058

Reference25 articles.

1. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985

2. ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS

3. Golimumab: A Novel Anti-Tumor Necrosis Factor

4. Golimumab Therapy of Rheumatoid Arthritis: An Overview

5. Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indicative features of tissue and microbial sensitization in the pathogenesis of generalized parodontitis associated with rheumatoid arthritis;Medicni perspektivi;2024-06-28

2. Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis;Rheumatology and Therapy;2023-07-17

3. Safety and Efficacy of Golimumab in Rheumatoid Arthritis: A Prospective, Multicenter, Real-World Study from India;Indian Journal of Rheumatology;2023-07-14

4. Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance;Modern Rheumatology;2023-07-03

5. Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy;International Journal of Rheumatic Diseases;2023-04-14